Economic Conditions: Overall economic health, including GDP growth, inflation rates, and interest rates, influences investor sentiment and investment decisions, affecting stock prices.

Company Performance: Company-specific factors, such as revenue, profitability, earnings reports, and debt levels, directly impact investor confidence and stock valuation.

Industry Trends: The overall performance and outlook of the pharmaceutical industry, including regulatory changes, drug approvals, and competitive landscape, affect the stock's attractiveness.

Market Sentiment: General investor mood, influenced by news events, global markets, and social trends, can drive buying or selling pressure, causing price fluctuations.

News & Events: Significant company announcements, industry updates, and global events can trigger immediate price changes due to altered investor expectations.

Regulatory Environment: Government policies, healthcare regulations, and drug pricing controls impact the company's operations and profitability, influencing investor perception.

Competition: Actions of competitors, new product launches, and market share shifts can affect the company's competitive position and stock price.

Financial Health: Key financial ratios, like liquidity, solvency, and profitability ratios, provide insights into the company's stability and growth potential, impacting stock valuation.

Dividend Policy: Decisions regarding dividend payouts and yield can attract or deter investors, affecting stock demand and price.

Technological Advancements: Breakthroughs in pharmaceutical research, drug development, and manufacturing processes can affect the company's future prospects and stock valuation.